We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-14.86%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$134B
AUM Growth
-$30.1B
Cap. Flow
-$1.57B
Cap. Flow %
-1.17%
Top 10 Hldgs %
29.15%
Holding
6,955
New
507
Increased
2,096
Reduced
2,889
Closed
579

Sector Composition

Rank Sector Weight
1 Technology 10.07%
2 Financials 5.69%
3 Healthcare 5.49%
4 Consumer Discretionary 4.41%
5 Industrials 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMBR
5751
Amber International Holding Ltd
AMBR
$132M
$2K ﹤0.01%
328
-3,457
-91% -$28.6K
ONIT
5752
Onity Group
ONIT
$341M
$2K ﹤0.01%
80
-318
-80% -$7.48K
FMTO
5753
DELISTED
Femto Technologies Inc. Common Stock
FMTO
0
ASBPW
5754
CALL
Aspire Biopharma Warrant
ASBPW
$579K
$2K ﹤0.01%
+13,950
New +$3.03K
NAGE
5755
Niagen Bioscience
NAGE
$262M
$2K ﹤0.01%
907
-3,009
-77% -$5.88K
CYTH
5756
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$2K ﹤0.01%
1,191
-41
-3% -$99
ACHL
5757
DELISTED
Achilles Therapeutics
ACHL
$2K ﹤0.01%
654
-190
-23% -$469
SYRS
5758
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2K ﹤0.01%
201
-161
-44% -$1.51K
GATO
5759
DELISTED
Gatos Silver, Inc.
GATO
$2K ﹤0.01%
777
-2,373
-75% -$8.33K
GRIN
5760
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
$2K ﹤0.01%
+100
New +$2.41K
HEWG
5761
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
$2K ﹤0.01%
93
TARO
5762
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2K ﹤0.01%
63
VAXX
5763
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$2K ﹤0.01%
+1,447
New +$5.47K
GMDA
5764
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$2K ﹤0.01%
909
-370
-29% -$940
SUNW
5765
DELISTED
Sunworks, Inc.
SUNW
$2K ﹤0.01%
+1,490
New +$2.84K
MDVL
5766
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$2K ﹤0.01%
22
+11
+100% +$965
RAIN
5767
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$2K ﹤0.01%
439
-838
-66% -$2.88K
ONCT
5768
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$2K ﹤0.01%
86
-9
-9% -$201
LVOX
5769
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$2K ﹤0.01%
1,398
-1,240
-47% -$3.06K
PATI
5770
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$2K ﹤0.01%
+295
New +$2.3K
FSRXW
5771
CALL
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$2K ﹤0.01%
13,459
FATH
5772
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$2K ﹤0.01%
32
+1
+3% +$114
SQZ
5773
DELISTED
SQZ Biotechnologies Company
SQZ
$2K ﹤0.01%
564
-1,020
-64% -$3.67K
RONI.WS
5774
CALL
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
$2K ﹤0.01%
6,251
BNNRW
5775
CALL
DELISTED
Banner Acquisition Corp. Warrants
BNNRW
$2K ﹤0.01%
+12,151
New +$3.57K

Similar funds

Citigroup's Q2 2022 Portfolio in Review

As of Q2 2022, Citigroup held 6,955 positions worth $134B, down 18% from $165B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citigroup's Q2 2022 filing shows 507 new, 2,096 increased, 2,889 reduced and 579 closed positions. Its largest new stake was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M. The largest sale was iShares Russell 2000 ETF, an estimated $565M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q2 2022 buy was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M.
  • Citigroup added most to Invesco QQQ Trust in Q2 2022, an estimated $628M increase.
  • Citigroup's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $565M.
  • Citigroup fully exited People's United Financial Inc in Q2 2022, selling an estimated $103M.
  • Citigroup's ten largest holdings make up 29% of its $134B portfolio in Q2 2022.
  • Citigroup opened 507 new positions and closed 579 in Q2 2022.
  • Citigroup's portfolio value fell 18% quarter-over-quarter to $134B.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.